COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping
COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Mucormycosis, a serious and rare fungal infection, has recently been reported in COVID-19 patients worldwide. This study aims to map all the emerging evidence on the COVID-19-associated mucormycosis (CAM) with a special focus on clinical presentation, treatment modalities, and patient outcomes. An extensive literature search was performed in MEDLIN...
Alternative Titles
Full title
COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8508302
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8508302
Other Identifiers
ISSN
1660-4601,1661-7827
E-ISSN
1660-4601
DOI
10.3390/ijerph181910340
